Hemostatic Gel for Trauma & Emergency Program
Emergency departments, trauma teams and EMS agencies standardizing bleeding control.
$2,500 program advisory · device and consumables quoted directly by the manufacturerRequest a proposal
The device
Cresilon — Traumagel. Intended use per the manufacturer’s current FDA clearance or approval: temporary control of moderate to severe bleeding. Indications, contraindications and training requirements are set by Cresilon; ClearLine confirms the current labeling with the manufacturer during the assessment.
What the advisory includes
Clinical and financial case for a Traumagel program at your site
Manufacturer engagement, quote and contract review with Cresilon or its authorized distributor
Credentialing, training, workflow and reimbursement plan
Go-live checklist and 90-day utilization review
How it works
1
Intake call: volumes, payer mix, current pathway
2
Program assessment and business case
3
Procurement support through contract
4
Launch plan and 90-day review
Who it’s for
Emergency departments, trauma teams and EMS agencies standardizing bleeding control.
Hemostatic Gel for Trauma & Emergency Program — $2,500
Request a proposalClearLine Healthcare Consulting is an independent advisor and is not affiliated with or endorsed by Cresilon. Equipment is purchased from the manufacturer or its authorized distributor under their terms.